These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26807209)

  • 1. Hepatitis C and insulin action: An intimate relationship.
    Knobler H; Malnick S
    World J Hepatol; 2016 Jan; 8(2):131-8. PubMed ID: 26807209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
    Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES.
    Andrade VG; Yamashiro FDS; Oliveira CV; Moreira A; Winckler FC; Silva GF
    Arq Gastroenterol; 2018; 55(3):274-278. PubMed ID: 30540091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.
    Desbois AC; Cacoub P
    World J Gastroenterol; 2017 Mar; 23(9):1697-1711. PubMed ID: 28321170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C.
    Conjeevaram HS; Wahed AS; Afdhal N; Howell CD; Everhart JE; Hoofnagle JH;
    Gastroenterology; 2011 Feb; 140(2):469-77. PubMed ID: 21070775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, steatosis and hepatitis C virus.
    Mangia A; Ripoli M
    Hepatol Int; 2013 Dec; 7 Suppl 2(Suppl 2):782-9. PubMed ID: 24587848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center.
    Gupta V; Kumar A; Sharma P; Bansal N; Singla V; Arora A
    J Clin Exp Hepatol; 2015 Jun; 5(2):134-41. PubMed ID: 26155041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.
    Koike K
    Hepatol Res; 2005 Oct; 33(2):145-50. PubMed ID: 16202646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.
    Doyle MA; Singer J; Lee T; Muir M; Cooper C
    Trials; 2016 Jul; 17(1):331. PubMed ID: 27439433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and steatosis in chronic hepatitis C.
    Machado MV; Cortez-Pinto H
    Ann Hepatol; 2009; 8 Suppl 1():S67-75. PubMed ID: 19381127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Type 2 diabetes mellitus, insulin resistance and hepatocellular carcinoma in chronic hepatitis C patients.
    Lombay B; Szilágyi R; Szalay F
    Orv Hetil; 2019 Oct; 160(40):1591-1602. PubMed ID: 31565976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.
    Abd El-Wahab EW; Mikheal A; Sidkey F; Shatat HZ
    J Med Virol; 2015 Mar; 87(3):428-40. PubMed ID: 25583244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose abnormalities in hepatitis C virus infection.
    Huang JF; Yu ML; Dai CY; Chuang WL
    Kaohsiung J Med Sci; 2013 Feb; 29(2):61-8. PubMed ID: 23347806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Hepatitis C Virus-Induced Diabetes Mellitus.
    Ashfaq UA; Khalid H
    Crit Rev Eukaryot Gene Expr; 2017; 27(4):363-371. PubMed ID: 29283331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Implication of Insulin Resistance in Chronic Hepatitis C Patients].
    Ogawa E
    Kansenshogaku Zasshi; 2015 Jan; 89(1):1-9. PubMed ID: 26548290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance.
    Bortoletto G; Scribano L; Realdon S; Marcolongo M; Mirandola S; Franceschini L; Bonisegna S; Noventa F; Plebani M; Martines D; Alberti A
    J Viral Hepat; 2010 Jul; 17(7):475-80. PubMed ID: 19878535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOES INSULIN RESISTANCE IMPAIR THE VIROLOGICAL RESPONSE TO PEGINTERFERON/RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS?
    Laurito MP; Silva GF; Cheinquer H; Sharma R; Verna E; Parise ER
    Arq Gastroenterol; 2018; 55(2):179-183. PubMed ID: 30043870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.